Live feed
Filing
SC 13G/A
SC 13G/A0001104659-24-022233·VANGUARD GROUP INC
Schedule 13G ownership disclosure
VERTEX PHARMACEUTICALS INC COM
Security class unavailable · CUSIP: 92532F100
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 22,281,729
- Percent of class
- 8.6500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-022233
- Form type
- SC 13G/A
- Filer
- VANGUARD GROUP INC
- CIK
- CIK 102909
- Filed
- Feb 13, 2024
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership